NBTX Trademark

Trademark Overview


On Saturday, July 11, 2020, a trademark application was filed for NBTX with the United States Patent and Trademark Office. The USPTO has given the NBTX trademark a serial number of 90048251. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by Nanobiotix. The NBTX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors; pharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors using radiotherapy; pharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors using radiotherapy and immunotherapy; X-ray enhancing agents for medical use for the diagnosis and treatment of tumors using radiotherapy, namely, radioenhancers; X-ray contrast agents for medical use for the diagnosis and treatment of tumors using radiotherapy, namely, radioenhancers; health goods, namely, pharmaceutical preparations for the treatment of tumors using radiotherapy and for the treatment of tumors using radiotherapy and immunotherapy; radiological contrast substances for medical use; nanoparticles for medical use; biological preparations with metallic nanoparticles and/or metal oxides for medical use; chem...

Injectable medical device containing inert metal for the diagnosis and treatment of tumors
nbtx

General Information


Serial Number90048251
Word MarkNBTX
Filing DateSaturday, July 11, 2020
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6624908
Registration DateTuesday, January 25, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesPharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors; pharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors using radiotherapy; pharmaceutical products, namely, preparations for medical use particularly for the diagnosis and treatment of tumors using radiotherapy and immunotherapy; X-ray enhancing agents for medical use for the diagnosis and treatment of tumors using radiotherapy, namely, radioenhancers; X-ray contrast agents for medical use for the diagnosis and treatment of tumors using radiotherapy, namely, radioenhancers; health goods, namely, pharmaceutical preparations for the treatment of tumors using radiotherapy and for the treatment of tumors using radiotherapy and immunotherapy; radiological contrast substances for medical use; nanoparticles for medical use; biological preparations with metallic nanoparticles and/or metal oxides for medical use; chemical preparations with metallic nanoparticles and/or metal oxides for medical or pharmaceutical use; medicinal products, namely, radioenhancers based on metallic nanoparticles and/or metal oxides for medical use for human medicine; chemical pharmaceutical products with metallic nanoparticles and/or metal oxides for the diagnosis of cancer
Goods and ServicesInjectable medical device containing inert metal for the diagnosis and treatment of tumors

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, August 8, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanobiotix
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressParis 75012
FR

Party NameNanobiotix
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParis 75012
FR

Party NameNanobiotix
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParis 75012
FR

Trademark Events


Event DateEvent Description
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 4, 2021EXAMINER'S AMENDMENT ENTERED
Monday, October 4, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 4, 2021EXAMINERS AMENDMENT E-MAILED
Monday, October 4, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, October 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 27, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, July 9, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 9, 2021LETTER OF SUSPENSION E-MAILED
Friday, July 9, 2021SUSPENSION LETTER WRITTEN
Friday, June 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 22, 2021ASSIGNED TO LIE
Thursday, April 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 8, 2020NON-FINAL ACTION E-MAILED
Thursday, October 8, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Saturday, August 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, July 15, 2020NEW APPLICATION ENTERED IN TRAM